News
NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...
NanoViricides, Inc. (NYSE American: NNVC) , a clinical-stage innovator in broad-spectrum antivirals, announced near-finalization of its adaptive clin ...
Shelton, Connecticut Thursday, July 17, 2025, 18:00 Hrs [IST] ...
Artificial Intelligence (AI) is no longer just a buzzword it is transforming the way healthcare is delivered and its influence is now reaching deep into the world of clinical trials from predicting ...
With clinical trials under pressure, industry leaders say it’s time for reform, digital transformation, and more patient-centric models.
Moleculin Biotech, Inc. 40+ year career at Roche founded on dedication to bringing new innovative medicines to patients and ...
In early research, OCU410ST, a gene therapy for Stargardt disease, demonstrated slowed lesion growth by 48% at the 12-month follow-up in evaluable treated eyes.
For decades, Alzheimer’s disease has resisted nearly every significant pharmaceutical intervention. Despite billions invested ...
Dementia associated with Alzheimer’s disease is a progressive neurodegenerative condition characterized by memory loss, cognitive decline, and impaired daily functioning. The growing aging population ...
The specific parameters defined in your label, including patient population, line of therapy, and outcomes measured, will now ...
This year, the EHA Congress provided us with long-term follow-up of some very interesting study, including the GAIA/CLL13 ...
Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results